A Hundred Years of Alzheimer's Disease Research

Neuron

Volumn 52, Issue 1, 2006, Pages 3-13

  Hardy, John ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; METAL CHELATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; DEMENTIA; DISEASE COURSE; DISEASE EXACERBATION; GENE MUTATION; GENETIC COUNSELING; GENETIC LINKAGE; HUMAN; IMMUNIZATION; MEDICAL RESEARCH; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; VASCULAR AMYLOIDOSIS;

ALZHEIMER DISEASE; ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; RESEARCH;

EID: 33749177143     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2006.09.016     Document Type: Short Survey

References (164)

1. Adolfsson R., Gottfries C.G., Roos B.E., and Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135 (1979) 216-223
2. Alzheimer A. Uber einen eigenartige Erkranung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und Psychisch-Gerichtisch Medizin 64 (1907) 146-148
3. Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S., and Ishiura S. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 301 (2003) 231-235
4. Atwood C.S., Bishop G.M., Perry G., and Smith M.A. Amyloid-beta, a vascular sealant that protects against hemorrhage?. J. Neurosci. Res. 70 (2002) 356
5. Atwood C.S., Perry G., and Smith M.A. Cerebral hemorrhage and amyloid-beta. Science 299 (2003) 1014
6. Bartus R.T. Physostigmine and recent memory, effects in young and aged nonhuman primates. Science 206 (1979) 1087-1089
7. Beach T. The history of Alzheimer's disease: three debates. J. Hist. Med. Allied Sci. 42 (1987) 327-349
8. Bertram L., and Tanzi R.E. Alzheimer's disease, one disorder, too many genes?. Hum. Mol. Genet. 13 Spec No 1 (2004) R135-R141
9. Bielschowsky M. Die Silberimprägnation der Achsencylinder. Neurologisches Zentralblatt. 21 (1902) 579-584
10. Bird T.D., Lampe T.H., Nemens E.J., Sumi S.M., Nochlin D., Schellenberg G.D., and Wijsman E.M. Characteristics of familial Alzheimer's disease in nine kindreds of Volga German ancestry. Prog. Clin. Biol. Res. 317 (1989) 229-234
11. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114 (1968) 797-811
12. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., and Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19 (1997) 939-945
13. Bowen D.M., Smith C.B., White P., and Davison A.N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99 (1976) 459-496
14. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82 (1991) 239-259
15. Brion J.P., Passareiro H., Nunez J., and Flament Durand J. Mise en evidence de la immunologique de la protein tau au lesions de degeneresescence neurofibrillaire de la maladie Alzheimer Arch. Biol. (Brux) 95 (1985) 229-235
16. Cai X.D., Golde T.E., and Younkin S.G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259 (1993) 514-516
17. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Hardy J., and Mullan M. Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 353 (1991) 844-846
18. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., et al. Related Articles, Links Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease, analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3 (1994) 569-574
19. Chen F., Hasegawa H., Schmitt-Ulms G., Kawarai T., Bohm C., Katayama T., Gu Y., Sanjo N., Glista M., Rogaeva E., et al. TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440 (2006) 1208-1212
20. Citron M. Beta-secretase inhibition for the treatment of Alzheimer's disease-promise and challenge. Trends Pharmacol Sci. 25 (2004) 92-97
21. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360 (1992) 672-674
22. Citron M., Teplow D.B., and Selkoe D.J. Generation of amyloid beta protein from its precursor is sequence specific. Neuron 14 (1995) 661-670
23. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
24. Crook R., Verkkoniemi A., Pérez-Tur J., Mehta N., Baker M., Houlden H., Farrer M., Hutton M., Lincoln S., Hardy J., et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat. Med. 4 (1998) 452-455
25. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2 (1976) 1403
26. Davis K.L., Mohs R.C., Tinklenberg J.R., Pfefferbaum A., Hollister L.E., and Kopell B.S. Physostigmine, improvement of long-term memory processes in normal humans. Science 201 (1978) 272-274
27. De Jonghe C., Zehr C., Yager D., Prada C.M., Younkin S., Hendriks L., Van Broeckhoven C., and Eckman C.B. Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol. Dis. 5 (1998) 281-286
28. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., and Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391 (1998) 387-390
29. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398 (1999) 518-522
30. Delabar J.M., Goldgaber D., Lamour Y., Nicole A., Huret J.L., de Grouchy J., Brown P., Gajdusek D.C., and Sinet P.M. Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science 235 (1987) 1390-1392
31. Dewachter I., Reverse D., Caluwaerts N., Ris L., Kuiperi C., Van den Haute C., Spittaels K., Umans L., Serneels L., Thiry E., et al. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J. Neurosci. 22 (2002) 3445-3453
32. Duff K., and Suleman F. Transgenic mouse models of Alzheimer's disease, how useful have they been for therapeutic development?. Brief Funct. Genomic. Proteomic. 3 (2004) 47-59
33. Duyckaerts C. Looking for the link between plaques and tangles. Neurobiol. Aging 25 (2004) 735-739 743-746
34. Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., and Haass C. Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5 (2003) 486-488
35. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., and Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248 (1990) 1122-1124
36. Essen-Moller E. A family with Alzheimer's disease. Acta. Psychiatr. Neurol. Scand 21 (1946) 233-244
37. Farrer L.A., Cupples L.A., van Duijn C.M., Kurz A., Zimmer R., Muller U., Green R.C., Clarke V., Shoffner J., Wallace D.C., et al. Apolipoprotein E genotype in patients with Alzheimer's disease, implications for the risk of dementia among relatives. Ann. Neurol. 38 (1995) 797-808
38. Foster N.L., Wilhelmsen K., Sima A.A., Jones M.Z., D'Amato C.J., and Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17, a consensus conference. Ann. Neurol. 41 (1997) 706-715
39. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373 (1995) 523-527
40. Glenner G.G., and Wong C.W. Alzheimer's disease, initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
41. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome, sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 (1984) 1131-1135
42. Goate A.M., Haynes A.R., Owen M.J., Farrall M., James L.A., Lai L.Y.C., Mullan M.J., Roques P., Rossor M.N., Williamson R., and Hardy J.A. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet i (1989) 352-355
43. Goate A.M., Chartier-Harlin M.C., Mullan M.C., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
44. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease, identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 85 (1988) 4051-4055
45. Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., and Gajdusek D.C. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235 (1987) 877-880
46. Graeber M.B., Kosel S., Grasbon-Frodl E., Moller H.J., and Mehraein P. Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. Neurogenetics 1 (1998) 223-228
47. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
48. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., Watkins P.C., Ottina K., Wallace M.R., Sakaguchi A.Y., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983) 234-238
49. Gustafson L., Brun A., Englund E., Hagnell O., Nilsson K., Stensmyr M., Ohlin A.K., and Abrahamson M. A 50-year perspective of a family with chromosome-14-linked Alzheimer's disease. Hum. Genet. 102 (1998) 253-257
50. Haass C., and Selkoe D.J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 75 (1993) 1039-1042
51. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
52. Hansen L.A., Masliah E., Galasko D., and Terry R.D. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J. Neuropathol. Exp. Neurol. 52 (1993) 648-654
53. Hardy J.A. Framing b-amyloid. Nature Genet. 1 (1992) 233-234
54. Hardy J., and Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12 (1991) 383-388
55. Hardy J.A., and Higgins G.A. Alzheimer's disease, the amyloid cascade hypothesis. Science 286 (1992) 184-185
56. Hardy J.A., Cowburn R., Barton A., Reynolds G., Lofdahl E., O'Carroll A.M., Wester P., and Winblad B. Region specific loss of glutamate innervation in Alzheimer's disease. Neurosci. Lett. 80 (1987) 73-77
57. Hardy J., Duff K., Hardy K.G., Perez-Tur J., and Hutton M. Genetic dissection of Alzheimer's disease and related dementias, amyloid and its relationship to tau. Nat. Neurosci. 1 (1998) 355-358
58. Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W., van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E., Martin J.J., et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet. 1 (1992) 218-221
59. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4 (1998) 97-100
60. Holtzman D.M. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23 (2004) 247-254
61. Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A.K., Zhang X.C., and Tang J. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290 (2000) 150-153
62. Hooper N.M., and Turner A.J. The search for alpha-secretase and its potential as a therapeutic approach to Alzheimer s disease. Curr. Med. Chem. 9 (2002) 1107-1119
63. Hornykiewicz O. Dopamine miracle, from brain homogenate to dopamine replacement. Mov. Disord. 17 (2002) 501-508
64. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
65. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
66. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., and Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals, evidence that an initially deposited species is A beta 42(43). Neuron 13 (1994) 45-53
67. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., et al. Ab peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408 (2000) 979-982
68. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
69. Katzman R. The prevalence and malignancy of Alzheimer disease. A major killer. Arch. Neurol. 33 (1976) 217-218
70. Khachaturian Z.S. The diagnosis of Alzheimer's disease, two decades of progress. J. Alzheimers Disease 9 (2006) 409-415
71. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197 (1963) 192-193
72. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55 (2004) 306-319
73. Kosik K.S., Joachim C.L., and Selkoe D.J. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA 83 (1986) 4044-4048
74. Kraepelin E. Das senile und prasenile Irresein. Psychiatrie, ein Lehrbuch fur Studierende und Arzte. 1910 (1910) 593-632
75. Laird F.M., Cai H., Savonenko A.V., Farah M.H., He K., Melnikova T., Wen H., Chiang H.C., Xu G., Koliatsos V.E., et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25 (2005) 11693-11709
76. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95 (1998) 6448-6453
77. Lantos P.L., Ovenstone I.M., Johnson J., Clelland C.A., Roques P., and Rossor M.N. Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci. Lett. 172 (1994) 77-79
78. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
79. Levitan D., and Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377 (1995) 351-354
80. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., van Duinen S.G., Bots G.T., Luyendijk W., and Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248 (1990) 1124-1126
81. Levy-Lahad E., Wijsman E.M., Nemens E., Anderson L., Goddard K.A., Weber J.L., Bird T.D., and Schellenberg G.D. A familial Alzheimer's disease locus on chromosome 1. Science 269 (1995) 970-973
82. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
83. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M., Yu X., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25 (2000) 402-405
84. Lewis J., Dickson D.W., Lin W.L., Chisholm L., Corral A., Jones G., Yen S.H., Sahara N., Skipper L., Yager D., et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293 (2001) 1487-1491
85. Lippa C.F., Fujiwara H., Mann D.M., Giasson B., Baba M., Schmidt M.L., Nee L.E., O'Connell B., Pollen D.A., St George-Hyslop P., et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor p rotein genes. Am. J. Pathol. 153 (1998) 1365-1370
86. Lippa C.F., Schmidt M.L., Lee V.M., and Trojanowski J.Q. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann. Neurol. 45 (1999) 353-357
87. Lleo A., Greenberg S.M., and Growdon J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57 (2006) 513-533
88. Martin J.J., Gheuens J., Bruyland M., Cras P., Vandenberghe A., Masters C.L., Beyreuther K., Dom R., Ceuterick C., Lubke U., et al. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology 41 (1991) 62-68
89. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice, implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
90. Masliah E., Rockenstein E., Veinbergs I., Sagara Y., Mallory M., Hashimoto M., and Mucke L. b-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. USA 98 (2001) 12245-12250
91. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82 (1985) 4245-4249
92. Maurer K., Volk S., and Gerbaldo H. Auguste D and Alzheimer's disease. Lancet 349 (1997) 1546-1549
93. McGeer P.L., and Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42 (1992) 447-449
94. Miyakawa T., and Uehara Y. Observations of amyloid angiopathy and senile plaques by the scanning electron microscope. Acta Neuropathol. (Berl.) 48 (1979) 153-156
95. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408 (2000) 982-985
96. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1 (1992) 345-347
97. Mullan M., Tsuji S., Miki T., Katsuya T., Naruse S., Kaneko K., Shimizu T., Kojima T., Nakano I., Ogihara T., et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene. Neurobiol. Aging 14 (1993) 407-419
98. Murray J.M., Davies K.E., Harper P.S., Meredith L., Mueller C.R., and Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 300 (1982) 69-71
99. Murrell J., Farlow M., Ghetti B., and Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254 (1991) 97-99
100. Newton R.D. The identity of Alzheimer's disease and their relationship to senility. J. Ment. Sci. 94 (1948) 225-249
101. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide, a case report. Nat. Med. 9 (2003) 448-452
102. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 6990-6995
103. Nukina N., and Ihara Y. One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. (Tokyo) 99 (1986) 1541-1544
104. Ohno M., Sametsky E.A., Younkin L.H., Oakley H., Younkin S.G., Citron M., Vassar R., and Disterhoft J.F. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41 (2004) 27-33
105. Pericak-Vance M.A., Bebout J.L., Gaskell Jr. P.C., Yamaoka L.H., Hung W.Y., Alberts M.J., Walker A.P., Bartlett R.J., Haynes C.A., Welsh K.A., et al. Linkage studies in familial Alzheimer disease, evidence for chromosome 19 linkage. Am. J. Hum. Genet. 48 (1991) 1034-1050
106. Perry E.K., Gibson P.H., Blessed G., Perry R.H., and Tomlinson B.E. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34 (1977) 247-265
107. Perusini G. The nosographic value of some characteristic histopathologic findings in senility. Rivista italiana di Neuropathologia, Psichiatria ed Elettroterapia 4 (1991) 193-213
108. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Related Mild cognitive impairment, clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
109. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
110. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825
111. Prasher V.P., Farrer M.J., Kessling A.M., Fisher E.M., West R.J., Barber P.C., and Butler A.C. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann. Neurol. 43 (1998) 380-383
112. Redlich F. Uber miliare Sklerose der Hirnrinde bei seniler Atrophie. Jarbucher fur Psychiatrie und Neurologie 1898 (1898) 17
113. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
114. Roses A.D. On the discovery of the genetic association of apolipoprotein E genotypes and the common late onset Alzheimer's disease. J. Alzheimer's Dis. 9 (2006) 361-366
115. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerriere A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet. 38 (2006) 24-26
116. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309 (2005) 476-481
117. Scahill R.I., Schott J.M., Stevens J.M., Rossor M.N., and Fox N.C. Mapping the evolution of regional atrophy in Alzheimer's disease, unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. USA 99 (2002) 4703-4707
118. Schellenberg G.D., Bird T.D., Wijsman E.M., Moore D.K., Boehnke M., Bryant E.M., Lampe T.H., Nochlin D., Sumi S.M., Deeb S.S., et al. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science 241 (1988) 1507-1510
119. Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E., White J.A., Bonnycastle L., Weber J.L., Alonso M.E., et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258 (1992) 668-671
120. Schenk D. Hopes remain for an Alzheimer's vaccine. Nature 431 (2004) 398
121. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
122. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2 (1996) 864-870
123. Schottky J. Uber prasenile Verblodungen. Gesamte Neurol. Psych. 140 (1932) 333-397
124. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
125. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
126. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
127. Sisodia S.S. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89 (1992) 6075-6079
128. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
129. Spillantini M.G., Bird T.D., and Ghetti B. Frontotemporal dementia and Parkinsonism linked to chromosome 17, a new group of tauopathies. Brain Pathol. 8 (1998) 387-402
130. St George-Hyslop P.H., Tanzi R.E., Polinsky R.J., Haines J.L., Nee L., Watkins P.C., Myers R.H., Feldman R.G., Pollen D., Drachman D., et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235 (1987) 885-890
131. St George-Hyslop P.H., Tanzi R.E., Polinsky R.J., Neve R.L., Pollen D., Drachman D., Growdon J., Cupples L.A., Nee L., Myers R.H., et al. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science 238 (1987) 664-666
132. St George-Hyslop P.H., Haines J.L., Farrer L.A., Polinsky R., Van Broeckhoven C., Goate A., McLachlan D.R., Orr H., Bruni A.C., Sorbi S., et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature 347 (1990) 194-197
133. St George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J.F., Montesi M., Bruni A., Sorbi S., et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat. Genet. 2 (1992) 330-334
134. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E, high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993) 1977-1981
135. Struhl G., and Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398 (1999) 522-525
136. Summers W.K., Majovski L.V., Marsh G.M., Tachiki K., and Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315 (1986) 1241-1245
137. Sumpter P.Q., Mann D.M., Davies C.A., Yates P.O., Snowden J.S., and Neary D. An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 12 (1986) 305-319
138. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos Jr. L., Eckman C., Golde T.E., and Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264 (1994) 1336-1340
139. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Hsiao Ashe K., Hasegawa M., Mann D.M., Hyman B.T., and Iwatsubo T. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am. J. Pathol. 157 (2000) 331-339
140. Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A., St George-Hyslop P., Van Keuren M.L., Patterson D., Pagan S., Kurnit D.M., and Neve R.L. Amyloid beta protein gene, cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235 (1987) 880-884
141. Tanzi R.E., St George-Hyslop P.H., Haines J.L., Polinsky R.J., Nee L., Foncin J.F., Neve R.L., McClatchey A.I., Conneally P.M., and Gusella J.F. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature 329 (1987) 156-157
142. Terry R.D., Gonatas N.K., and Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44 (1964) 269-297
143. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 7 (1968) 331-356
144. Tomlinson B.E., Blessed G., and Roth M. Observations on the brains of demented old people. J. Neurol. Sci. 11 (1970) 205-242
145. Van Bogaert L., and Maert M. De Smedt. (1940). Sur les formes familiares precoces de la maladie d'Alzheimer. Monatschr Psychiatrie 102 (1940) 249
146. Van Broeckhoven C., Haan J., Bakker E., Hardy J.A., Van Hul W., Wehnert A., Vegter-Van der Vlis M., and Roos R.A.C. The beta-amyloid precursor protein gene is tightly linked to the locus causing Hereditary Cerebral Hemorrhage with Amyloidosis of Dutch Type. Science 248 (1990) 488-490
147. Van Broeckhoven C., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., and Martin J.J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat. Genet. 2 (1992) 335-339
148. van Duinen S.G., Castano E.M., Prelli F., Bots G.T., Luyendijk W., and Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc. Natl. Acad. Sci. USA 84 (1987) 5991-5994
149. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999) 735-741
150. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
151. Webster S., Lue L.F., Brachova L., Tenner A.J., McGeer P.L., Terai K., Walker D.G., Bradt B., Cooper N.R., and Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging 18 (1997) 415-421
152. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414 (2001) 212-216
153. Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J.M., Masters C.L., and Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57 (1989) 115-126
154. Weingarten M.D., Lockwood A.H., Hwo S.Y., and Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA 72 (1975) 1858-1862
155. Wenk H., Bigl V., and Meyer U. Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res. 2 (1980) 295-316
156. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delong M.R. Alzheimer's disease and senile dementia, loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
157. Wilhelmsen K.C., Lynch T., Pavlou E., Higgins M., and Nygaard T.G. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55 (1994) 1159-1165
158. Winblad B., and Blum K.I. Hints of a therapeutic vaccine for Alzheimer's?. Neuron 38 (2003) 517-518
159. Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T., and
160. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., and Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387 (1997) 288-292
161. Wood J.G., Mirra S.S., Pollock N.J., and Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 83 (1986) 4040-4043
162. Xia X., Qian S., Soriano S., Wu Y., Fletcher A.M., Wang X.J., Koo E.H., Wu X., and Zheng H. Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc. Natl. Acad. Sci. USA 98 (2001) 10863-10868
163. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein, reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
164. Yu H., Saura C.A., Choi S.Y., Sun L.D., Yang X., Handler M., Kawarabayashi T., Younkin L., Fedeles B., Wilson M.A., et al. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 31 (2001) 713-726